BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15893021)

  • 1. Novel Cu(II) quinoxaline N1,N4-dioxide complexes as selective hypoxic cytotoxins.
    Torre MH; Gambino D; Araujo J; Cerecetto H; González M; Lavaggi ML; Azqueta A; López de Cerain A; Vega AM; Abram U; Costa-Filho AJ
    Eur J Med Chem; 2005 May; 40(5):473-80. PubMed ID: 15893021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives.
    Vieites M; Noblía P; Torre MH; Cerecetto H; Laura Lavaggi M; Costa-Filho AJ; Azqueta A; de Cerain AL; Monge A; Parajón-Costa B; González M; Gambino D
    J Inorg Biochem; 2006 Aug; 100(8):1358-67. PubMed ID: 16698084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.
    Urquiola C; Vieites M; Torre MH; Cabrera M; Lavaggi ML; Cerecetto H; González M; Cerain AL; Monge A; Smircich P; Garat B; Gambino D
    Bioorg Med Chem; 2009 Feb; 17(4):1623-9. PubMed ID: 19162490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New copper-based complexes with quinoxaline N1,N4-dioxide derivatives, potential antitumoral agents.
    Urquiola C; Gambino D; Cabrera M; Lavaggi ML; Cerecetto H; González M; de Cerain AL; Monge A; Costa-Filho AJ; Torre MH
    J Inorg Biochem; 2008 Jan; 102(1):119-26. PubMed ID: 17804074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
    Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
    J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of some novel CoII and CoIII complexes by tribochemical reactions using KI with some derivatives of thiosemicarbazide complexes derived from Girard's T and P.
    Al-Ashqar SM; Mostafa MM
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Dec; 71(4):1321-6. PubMed ID: 18534903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.
    Urquiola C; Vieites M; Aguirre G; Marín A; Solano B; Arrambide G; Noblía P; Lavaggi ML; Torre MH; González M; Monge A; Gambino D; Cerecetto H
    Bioorg Med Chem; 2006 Aug; 14(16):5503-9. PubMed ID: 16709457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization and dioxygen reactivity of copper(I) complexes with glycoligands.
    Damaj Z; Cisnetti F; Dupont L; Henon E; Policar C; Guillon E
    Dalton Trans; 2008 Jun; (24):3235-45. PubMed ID: 18688422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic, spectral, magnetic and in vitro cytotoxic activity studies of cobalt(II) complexes with cytokinin derivatives: X-ray structure of 6-(3-methoxybenzylamino)purinium chloride monohydrate.
    Trávnícek Z; Klanicová A; Popa I; Rolcík J
    J Inorg Biochem; 2005 Mar; 99(3):776-86. PubMed ID: 15708799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectroscopic characterization of copper(II) complexes of indoxyl N(4)-methyl thiosemicarbazone.
    Chandra S; Kumar U
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 Oct; 60(12):2825-9. PubMed ID: 15350918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and electronic differences of copper(I) complexes with tris(pyrazolyl)methane and hydrotris(pyrazolyl)borate ligands.
    Fujisawa K; Ono T; Ishikawa Y; Amir N; Miyashita Y; Okamoto K; Lehnert N
    Inorg Chem; 2006 Feb; 45(4):1698-713. PubMed ID: 16471983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and cytotoxic activity of copper(II) and platinum(II) complexes of 2-benzoylpyrrole and X-ray structure of bis[2-benzoylpyrrolato(N,O)]copper(II).
    Rubino S; Petruso S; Pierattelli R; Bruno G; Stocco GC; Steardo L; Motta M; Passerotto M; Giudice ED; Gulì G
    J Inorg Biochem; 2004 Dec; 98(12):2071-9. PubMed ID: 15541496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding studies of novel Copper(II) complexes containing L-tryptophan as chiral auxiliary: in vitro antitumor activity of Cu-Sn2 complex in human neuroblastoma cells.
    Chauhan M; Banerjee K; Arjmand F
    Inorg Chem; 2007 Apr; 46(8):3072-82. PubMed ID: 17378549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
    Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
    Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper(II) and uranyl(II) complexes with acylthiosemicarbazide: synthesis, characterization, antibacterial activity and effects on the growth of promyelocytic leukemia cells HL-60.
    Angelusiu MV; Almajan GL; Rosu T; Negoiu M; Almajan ER; Roy J
    Eur J Med Chem; 2009 Aug; 44(8):3323-9. PubMed ID: 19356828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part III.
    Cerecetto H; González M; Risso M; Saenz P; Olea-Azar C; Bruno AM; Azqueta A; De Ceráin AL; Monge A
    Arch Pharm (Weinheim); 2004 May; 337(5):271-80. PubMed ID: 15095420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(II) complexes of tridentate pyridylmethylethylenediamines: role of ligand steric hindrance on DNA binding and cleavage.
    Raja A; Rajendiran V; Uma Maheswari P; Balamurugan R; Kilner CA; Halcrow MA; Palaniandavar M
    J Inorg Biochem; 2005 Aug; 99(8):1717-32. PubMed ID: 16039720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures, spectra, and DNA-binding properties of mixed ligand copper(II) complexes of iminodiacetic acid: the novel role of diimine co-ligands on DNA conformation and hydrolytic and oxidative double strand DNA cleavage.
    Selvakumar B; Rajendiran V; Uma Maheswari P; Stoeckli-Evans H; Palaniandavar M
    J Inorg Biochem; 2006 Mar; 100(3):316-30. PubMed ID: 16406550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular structure, bioavailability and bioactivity of [Cu(o-phen)2(cnge)](NO3)2.2H2O and [Cu(o-phen)(cnge)(H2O)(NO3)2] complexes.
    Ferrer EG; López Tévez LL; Baeza N; Correa MJ; Okulik N; Lezama L; Rojo T; Castellano EE; Piro OE; Williams PA
    J Inorg Biochem; 2007 May; 101(5):741-9. PubMed ID: 17331582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.